Home / Market News / $BSEM

$BSEM news and market catalysts

The 5 most recent market catalysts affecting $BSEM, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 2 high impact 1 bullish 2 bearish Biotechnology
Sep 18, 2026 Corporate Catalyst Bullish Impact 85
BioStem Technologies shares are trading higher after the company announced it entered into a $40 million Committed Equity Facility with Roth Principal Investments.
This headline represents a significant corporate catalyst for BioStem Technologies. The $40 million committed equity facility provides a substantial capital injection, addressing p…
Sep 18, 2026 Corporate Catalyst Neutral Impact 75
BioStem Technologies Announces $40M Committed Equity Facility With Roth Principal Investments For Working Capital, General Corporate Purposes
The $40M committed equity facility provides BioStem Technologies (BSEM) with crucial working capital and funds for general corporate purposes, significantly de-risking its financia…
Aug 13, 2026 Corporate Catalyst Bearish Impact 75
BioStem Technologies shares are trading lower after the company reported a year-over-year decrease in Q2 sales results.
The headline indicates a direct corporate catalyst impacting BioStem Technologies (BSEM). A year-over-year decrease in Q2 sales is a strong negative signal to investors, suggesting…
Aug 12, 2026 Corporate Catalyst Bearish Impact 92
BioStem Technologies Q2 EPS $(0.52), Sales $7.899M Down From $10.963M YoY
BioStem Technologies (BSEM) announced its Q2 earnings, reporting a loss of $(0.52) per share and sales of $7.899 million. This represents a substantial 27.95% year-over-year decrea…
Aug 6, 2026 Corporate Catalyst Neutral Impact 65
BioStem Technologies Announces It Received Nasdaq Approval For The Company’s Common Stock For Listing On The Nasdaq Capital Market; Co. To Begin Trading On Nasdaq On August 7, 2026 Under The Ticker Symbol "BSEM"
BioStem Technologies announced that Nasdaq has approved its common stock for listing on The Nasdaq Capital Market. This is a positive development for the company as uplisting to a …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.